The expression of Egfl7 in human normal tissues and epithelial tumors

International Journal of Biological Markers

Volumn 28, Issue 1, 2013, Pages 71-83

  Fan, Chun ^a   Yang, Lian Yue ^a   Wu, Fan ^a   Tao, Yi Ming ^a   Liu, Lin Sen ^a   Zhang, Jin Fan ^a   He, Ya Ning ^a   Tang, Li Li ^a   Chen, Guo Dong ^a   Guo, Lei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Biomarker; Epidermal growth factor like domain 7; Epithelial tumor; Expression profile; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR LIKE DOMAIN 7; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM TUMOR; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; ORGAN SPECIFICITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84876708186     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/JBM.2013.10568     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Andre F, McShane LM, Michiels S, et al. Biomarker studies: a call for a comprehensive biomarker study registry. Nat Rev Clin Oncol 2011; 8: 171-6.
3. Fang F, Chang R, Yang L. Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo. Cancer 2012; 118: 1782-94.
4. Servais EL, Suzuki K, Colovos C, et al. An in vivo platform for tumor biomarker assessment. PLoS One 2011; 6: e26722.
5. Fang F, Yang L, Tao Y, Qin W. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Cancer 2012; 118: 134-46.
6. Kalinina J, Peng J, Ritchie JC, Van Meir EG. Proteomics of gliomas: initial biomarker discovery and evolution of technology. Neuro Oncol 2011; 13: 926-42.
7. Tolles J, Bai Y, Baquero M, Harris LN, Rimm DL, Molinaro AM. Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma. Breast Cancer Res 2011; 13: R51.
8. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-76.
9. Nichol D, Stuhlmann H. EGFL7: a unique angiogenic signaling factor in vascular development and disease. Blood 2012; 119: 1345-52.
10. Parker LH, Schmidt M, Jin SW, et al. The endothelial-cellderived secreted factor Egfl7 regulates vascular tube formation. Nature 2004; 428: 754-8.
11. Fitch MJ, Campagnolo L, Kuhnert F, Stuhlmann H. Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev Dyn 2004; 230: 316-24.
12. Campagnolo L, Moscatelli I, Pellegrini M, Siracusa G, Stuhlmann H. Expression of EGFL7 in primordial germ cells and in adult ovaries and testes. Gene Expr Patterns 2008; 8: 389-96.
13. Campagnolo L, Leahy A, Chitnis S, et al. EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. Am J Pathol 2005; 167: 275-84.
14. Schmidt M, Paes K, De Mazière A, et al. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 2007; 134: 2913-23.
15. Ruoslahti E, Seppälä M. alpha-Fetoprotein in cancer and fetal development. Adv Cancer Res 1979; 29: 275-346.
16. Bacolod MD, Barany F. Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition. Ann Surg Oncol 2011; 18: 3694-700.
17. Malaguarnera G, Giordano M, Paladina I, Berretta M, Cappellani A, Malaguarnera M. Serum markers of hepatocellular carcinoma. Dig Dis Sci 2010; 55: 2744-55.
18. Wu F, Yang LY, Li YF, Ou DP, Chen DP, Fan C. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology 2009; 50: 1839-50.
19. Díaz R, Silva J, García JM, et al. Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer 2008; 47: 794-802.
20. Huang CH, Li XJ, Zhou YZ, Luo Y, Li C, Yuan XR. Expression and clinical significance of EGFL7 in malignant glioma. J Cancer Res Clin Oncol 2010; 136: 1737-43.
21. Li JJ, Yang XM, Wang SH, Tang QL. Prognostic role of epidermal growth factor-like domain 7 protein expression in laryngeal squamous cell carcinoma. J Laryngol Otol 2011; 125: 1152-7.
22. Azhikina T, Kozlova A, Skvortsov T, Sverdlov E. Heterogeneity and degree of TIMP4, GATA4, SOX18, and EGFL7 gene promoter methylation in non-small cell lung cancer and surrounding tissues. Cancer Genet 2011; 204: 492-500.
23. Wright LM, Kreikemeier JT, Fimmel CJ. A concise review of serum markers for hepatocellular cancer. Cancer Detect Prev 2007; 31: 35-44.
24. Huang GL, Li BK, Zhang MY, et al. Allele loss and downregulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma. PLoS One 2012; 7: e44061.
25. Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg 2009; 249: 118-23.
26. Ha SA, Lee YS, Kim HK, et al. The prognostic potential of keratin 18 in breast cancer associated with tumor dedifferentiation, and the loss of estrogen and progesterone receptors. Cancer Biomark 2011; 10: 219-31.
27. Delfortrie S, Pinte S, Mattot V, et al. Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation. Cancer Res 2011; 71: 7176-86.